What are the new drugs for HER2-negative breast cancer?

Hi Alison! This is so exciting. I think the best path to getting the information you need is to ask one of our oncology nurses for the specifics. Go to the homepage of the app and scroll to the bottom where you will see an Ask Outcomes4Me box. Put your question there and it will send an email to our nurses who will get back to you 1:1. I hope you are well and feeling empowered in your treatment choices! Suzanne (Community Moderator)

Enhertu is on of the new drugs. Supposed to be brillant drug

Recent research presented at ASCO has shown promising results with antibody-drug conjugates (ADCs) like trastuzumab deruxtecan for HER2-low breast cancers, which were previously grouped with HER2-negative cancers. This represents an exciting development that may expand treatment options for patients who have low levels of HER2 expression. It's wonderful that you're staying informed about the latest research - discussing these findings with your oncology team can help determine what treatment approaches might be most appropriate for your specific situation.